Provided by Tiger Trade Technology Pte. Ltd.

Applied Therapeutics Inc.

0.1030
0.0000
Volume:- -
Turnover:- -
Market Cap:14.86M
PE:-0.83
High:0.1030
Open:0.1030
Low:0.1030
Close:0.1030
52wk High:1.50
52wk Low:0.0900
Shares:144.30M
Float Shares:120.21M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1236
EPS(LYR):-0.7570
ROE:-680.47%
ROA:-88.35%
PB:-26.49
PE(LYR):-0.14

Loading ...

Cycle Pharmaceuticals übernimmt Applied Therapeutics

Reuters
·
Feb 03

Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer

THOMSON REUTERS
·
Jan 30

Applied Therapeutics Urges Shareholders to Tender Shares as Cycle Group Acquisition Offer Extended

Reuters
·
Jan 29

Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension

GlobeNewswire
·
Jan 29

NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM

Reuters
·
Jan 28

Applied Therapeutics Director Stacy J. Kanter Reports Disposal of Common Shares

Reuters
·
Dec 19, 2025

BUZZ-U.S. STOCKS ON THE MOVE-EastGroup, Boeing, Exxon Mobil

Reuters
·
Dec 13, 2025

BUZZ-U.S. STOCKS ON THE MOVE-ProPetro, Nvidia, Citigroup

Reuters
·
Dec 12, 2025

Applied Therapeutics Shares Tumble 48.2% to an All-Time Low After Cycle Therapeutics to Buy Co at $0.088 per Share

THOMSON REUTERS
·
Dec 12, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Lululemon, Gold miners, Silver miners

Reuters
·
Dec 12, 2025

BUZZ-Applied Therapeutics plunges after UK's Cycle Group to buy co

Reuters
·
Dec 12, 2025

Applied Therapeutics Shares Slump 35% Premarket After Cycle Therapeutics to Buy Co at $0.088 per Share

THOMSON REUTERS
·
Dec 12, 2025

Cycle Pharmaceuticals to Acquire Applied Therapeutics for $0.088 Per Share Plus CVR

Reuters
·
Dec 12, 2025

NASDAQ TRADE HALT HALT NEWS PENDING AT 05:21 PM

Reuters
·
Dec 12, 2025

Applied Therapeutics Cuts Workforce and Explores Strategic Alternatives

Reuters
·
Nov 20, 2025

Applied Therapeutics Inc - to Reduce Workforce by 46%

THOMSON REUTERS
·
Nov 20, 2025

Applied Therapeutics: Expects to Submit Request for Additional Type C Meeting With FDA to Further Discuss Potential Phase 3 Trial Design

THOMSON REUTERS
·
Nov 20, 2025

RBC Capital Remains a Hold on Applied Therapeutics (APLT)

TIPRANKS
·
Nov 15, 2025

Are Applied Therapeutics' (APLT) Narrowing Losses a Turning Point for Its Strategic Vision?

Simply Wall St.
·
Nov 15, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO)

TIPRANKS
·
Nov 14, 2025